Overview
Kyoko Hirakawa practices practicing medicine in Kumamoto, Japan.
Ms. Hirakawa is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Primary Amyloidosis, Familial Transthyretin Amyloidosis, and Tissue Biopsy.
She is actively involved in clinical research, co-authoring 52 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kyoko Hirakawa
Is Kyoko Hirakawa a top-rated expert for Transthyretin Amyloid Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Kyoko Hirakawa is classified as an Distinguished expert for Transthyretin Amyloid Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kyoko Hirakawa participate in research or clinical trials?
Yes. Kyoko Hirakawa has published 52 articles and abstracts on conditions like Transthyretin Amyloid Cardiomyopathy. You can view a list of Kyoko Hirakawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cardiac AmyloidosisMs. Hirakawa isDistinguished. Learn about Cardiac Amyloidosis.
- Transthyretin Amyloid CardiomyopathyMs. Hirakawa isDistinguished. Learn about Transthyretin Amyloid Cardiomyopathy.
- Advanced
- CardiomyopathyMs. Hirakawa isAdvanced. Learn about Cardiomyopathy.
- Familial Transthyretin AmyloidosisMs. Hirakawa isAdvanced. Learn about Familial Transthyretin Amyloidosis.
- Idiopathic Dilatation of the Pulmonary Artery
- Primary AmyloidosisMs. Hirakawa isAdvanced. Learn about Primary Amyloidosis.
- Tissue BiopsyMs. Hirakawa isAdvanced. Learn about Tissue Biopsy.
- Transthyretin AmyloidosisMs. Hirakawa isAdvanced. Learn about Transthyretin Amyloidosis.
- Experienced
- Atrial TachycardiaMs. Hirakawa isExperienced. Learn about Atrial Tachycardia.
- Endomyocardial FibrosisMs. Hirakawa isExperienced. Learn about Endomyocardial Fibrosis.
- Heart AttackMs. Hirakawa isExperienced. Learn about Heart Attack.
- Heart FailureMs. Hirakawa isExperienced. Learn about Heart Failure.
- HypertensionMs. Hirakawa isExperienced. Learn about Hypertension.
- Pulmonary HypertensionMs. Hirakawa isExperienced. Learn about Pulmonary Hypertension.